R. Siegel, K. Miller, and A. Jemal, Cancer statistics, 2016, CA: A Cancer Journal for Clinicians, vol.61, issue.suppl 3, pp.7-30, 2016.
DOI : 10.3322/caac.20134

A. Toss and M. Cristofanilli, Molecular characterization and targeted therapeutic approaches in breast cancer, Breast Cancer Research, vol.25, issue.Suppl 2, p.60, 2015.
DOI : 10.1093/annonc/mdu112

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407294

J. Thiery, X. Sastre-garau, B. Vincent-salomon, X. Sigal-zafrani, J. Pierga et al., Challenges in the stratification of breast tumors for tailored therapies, Bull Cancer, vol.93, issue.8, pp.81-90, 2006.

D. Hanahan and R. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

T. Shimada, T. Kawai, K. Takeda, M. Matsumoto, J. Inoue et al., IKK-i, a novel lipopolysaccharide-inducible kinase that is related to I??B kinases, International Immunology, vol.11, issue.8, pp.1357-62, 1999.
DOI : 10.1093/intimm/11.8.1357

R. Peters, S. Liao, and T. Maniatis, IKK?? Is Part of a Novel PMA-Inducible I??B Kinase Complex, Molecular Cell, vol.5, issue.3, pp.513-535, 2000.
DOI : 10.1016/S1097-2765(00)80445-1

M. Adli and A. Baldwin, IKK-i/IKK?? Controls Constitutive, Cancer Cell-associated NF-??B Activity via Regulation of Ser-536 p65/RelA Phosphorylation, Journal of Biological Chemistry, vol.19, issue.37, pp.26976-84, 2006.
DOI : 10.1074/jbc.C400442200

I. Mattioli, H. Geng, A. Sebald, M. Hodel, C. Bucher et al., Inducible Phosphorylation of NF-??B p65 at Serine 468 by T Cell Costimulation Is Mediated by IKK??, Journal of Biological Chemistry, vol.269, issue.10, pp.6175-83, 2006.
DOI : 10.1016/S1097-2765(02)00477-X

J. Harris, S. Oliere, S. Sharma, Q. Sun, R. Lin et al., Nuclear Accumulation of cRel following C-Terminal phosphorylation by TBK1/IKK??, The Journal of Immunology, vol.177, issue.4, pp.2527-2562, 2006.
DOI : 10.4049/jimmunol.177.4.2527

S. Sharma, B. Tenoever, N. Grandvaux, G. Zhou, R. Lin et al., Triggering the Interferon Antiviral Response Through an IKK-Related Pathway, Science, vol.300, issue.5622, pp.1148-51, 2003.
DOI : 10.1126/science.1081315

K. Fitzgerald, S. Mcwhirter, K. Faia, D. Rowe, E. Latz et al., IKK?? and TBK1 are essential components of the IRF3 signaling pathway, Nature Immunology, vol.4, issue.5, pp.491-497, 2003.
DOI : 10.1038/ni921

B. Tenoever, S. Ng, M. Chua, S. Mcwhirter, A. Garcia-sastre et al., Multiple Functions of the IKK-Related Kinase IKK?? in Interferon-Mediated Antiviral Immunity, Science, vol.17, issue.6, pp.1274-1282, 2007.
DOI : 10.1016/j.molcel.2005.02.021

J. Boehm, J. Zhao, J. Yao, S. Kim, R. Firestein et al., Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene, Cell, vol.129, issue.6, pp.1065-79, 2007.
DOI : 10.1016/j.cell.2007.03.052

URL : http://doi.org/10.1016/j.cell.2007.03.052

S. Eddy, S. Guo, E. Demicco, R. Romieu-mourez, E. Landesman-bollag et al., Inducible I??B Kinase/I??B Kinase ?? Expression Is Induced by CK2 and Promotes Aberrant Nuclear Factor-??B Activation in Breast Cancer Cells, Cancer Research, vol.65, issue.24, pp.11375-83, 2005.
DOI : 10.1158/0008-5472.CAN-05-1602

J. Hutti, R. Shen, D. Abbott, A. Zhou, K. Sprott et al., Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKK?? Promotes Cell Transformation, Molecular Cell, vol.34, issue.4, pp.461-72, 2009.
DOI : 10.1016/j.molcel.2009.04.031

R. Shen, A. Zhou, E. Kim, E. Lim, H. Habelhah et al., I??B Kinase ?? Phosphorylates TRAF2 To Promote Mammary Epithelial Cell Transformation, Molecular and Cellular Biology, vol.32, issue.23, pp.4756-68, 2012.
DOI : 10.1128/MCB.00468-12

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497603

J. Guo, W. Tian, S. Shu, Y. Xin, C. Shou et al., IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function, PLoS ONE, vol.42, issue.5, p.63636, 2013.
DOI : 10.1371/journal.pone.0063636.s003

B. Qin and K. Cheng, Silencing of the IKK?? gene by siRNA inhibits invasiveness and growth of breast cancer cells, Breast Cancer Research, vol.285, issue.5, p.74, 2010.
DOI : 10.1074/jbc.M109.078212

J. Guo, D. Coppola, and J. Cheng, IKBKE Protein Activates Akt Independent of Phosphatidylinositol 3-Kinase/PDK1/mTORC2 and the Pleckstrin Homology Domain to Sustain Malignant Transformation, Journal of Biological Chemistry, vol.166, issue.43, pp.37389-98, 2011.
DOI : 10.2174/156802610790980602

T. Barbie, G. Alexe, A. Aref, S. Li, Z. Zhu et al., Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth, Journal of Clinical Investigation, vol.124, issue.12, pp.5411-5434, 2014.
DOI : 10.1172/JCI75661DS1

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348940

J. Guo, S. Shu, N. Esposito, D. Coppola, J. Koomen et al., IKK?? Phosphorylation of Estrogen Receptor ?? Ser-167 and Contribution to Tamoxifen Resistance in Breast Cancer, Journal of Biological Chemistry, vol.61, issue.6, pp.3676-84, 2010.
DOI : 10.1074/jbc.274.36.25245

M. Demers, A. Rose, A. Grosset, K. Biron-pain, L. Gaboury et al., Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells, The American Journal of Pathology, vol.176, issue.6, pp.3023-3054, 2010.
DOI : 10.2353/ajpath.2010.090876

URL : https://hal.archives-ouvertes.fr/pasteur-00819591

A. Grosset, M. Labrie, M. Vladoiu, E. Yousef, L. Gaboury et al., Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets, Oncotarget, vol.7, issue.14, pp.18183-203, 2016.
DOI : 10.18632/oncotarget.7784

URL : https://hal.archives-ouvertes.fr/pasteur-01351190

E. Mukawera, S. Chartier, V. Williams, P. Pagano, R. Lapointe et al., Redox-modulating agents target NOX2-dependent IKK?? oncogenic kinase expression and proliferation in human breast cancer cell lines, Redox Biology, vol.6, pp.9-18, 2015.
DOI : 10.1016/j.redox.2015.06.010

B. Peant, V. Forest, V. Trudeau, M. Latour, A. Mes-masson et al., I??B-Kinase-?? (IKK??/IKKi/I??BK??) expression and localization in prostate cancer tissues, The Prostate, vol.65, issue.24, pp.1131-1139, 2011.
DOI : 10.1158/0008-5472.CAN-05-1602

Y. Wang, X. Lu, L. Zhu, Y. Shen, S. Chengedza et al., IKK epsilon kinase is crucial for viral G protein-coupled receptor tumorigenesis, Proceedings of the National Academy of Sciences, vol.7, issue.11, pp.11139-11183, 2013.
DOI : 10.1371/journal.ppat.1002336

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703966

J. Ro, S. North, G. Gallick, G. Hortobagyi, J. Gutterman et al., Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma, Cancer Res, vol.48, issue.1, pp.161-165, 1988.

F. Weber, K. Fukino, T. Sawada, N. Williams, K. Sweet et al., Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors, British Journal of Cancer, vol.10, issue.10, pp.1922-1928, 2005.
DOI : 10.1126/science.1099314

N. Normanno, D. Luca, A. Bianco, C. Strizzi, L. Mancino et al., Epidermal growth factor receptor (EGFR) signaling in cancer, Gene, vol.366, issue.1, pp.2-16, 2006.
DOI : 10.1016/j.gene.2005.10.018

M. Guerin, M. Gabillot, M. Mathieu, J. Travagli, M. Spielmann et al., Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: Prognostic significance, International Journal of Cancer, vol.49, issue.2
DOI : 10.1128/MCB.7.5.2019

M. Tischkowitz, J. Brunet, L. Begin, D. Huntsman, M. Cheang et al., Use of immunohistochemical markers can refine prognosis in triple negative breast cancer, BMC Cancer, vol.50, issue.4, p.134, 2007.
DOI : 10.1111/j.1365-2559.2007.02638.x

A. Lluch, P. Eroles, and J. Perez-fidalgo, Emerging EGFR antagonists for breast cancer, Expert Opinion on Emerging Drugs, vol.94, issue.6, pp.165-81, 2014.
DOI : 10.1007/s10549-012-1997-5

H. Masuda, D. Zhang, C. Bartholomeusz, H. Doihara, G. Hortobagyi et al., Role of epidermal growth factor receptor in breast cancer, Breast Cancer Research and Treatment, vol.7, issue.2, pp.331-376, 2012.
DOI : 10.3816/CBC.2006.n.040

S. Challa, J. Guo, X. Ding, C. Xu, Y. Li et al., IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFR, Cancer Research, vol.76, issue.15, pp.4418-4447, 2016.
DOI : 10.1158/0008-5472.CAN-16-0069

J. Guo, S. Shu, L. He, Y. Lee, P. Kruk et al., Deregulation of IKBKE Is Associated with Tumor Progression, Poor Prognosis, and Cisplatin Resistance in Ovarian Cancer, The American Journal of Pathology, vol.175, issue.1, pp.324-357, 2009.
DOI : 10.2353/ajpath.2009.080767

S. Lee, M. Hong, J. Cho, J. Lee, and K. Kim, IKKepsilon and TBK1 expression in gastric cancer, Oncotarget, 2016.
DOI : 10.18632/oncotarget.9069

E. Niederberger, C. Moser, K. Kynast, and G. Geisslinger, The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs, Current Molecular Medicine, vol.13, issue.7, pp.1089-97, 2013.
DOI : 10.2174/1566524011313070004

N. Grandvaux, La kinase IKK??, m??decine/sciences, vol.27, issue.6-7, pp.619-644, 2011.
DOI : 10.1051/medsci/2011276014

K. Clark, M. Peggie, L. Plater, R. Sorcek, E. Young et al., Novel cross-talk within the IKK family controls innate immunity, Biochemical Journal, vol.5, issue.1, pp.93-104, 2011.
DOI : 10.1128/MCB.01101-07

URL : https://hal.archives-ouvertes.fr/hal-00560693

E. Mciver, J. Bryans, K. Birchall, J. Chugh, T. Drake et al., Synthesis and structure???activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKK?? kinases, Bioorganic & Medicinal Chemistry Letters, vol.22, issue.23, pp.7169-73, 2012.
DOI : 10.1016/j.bmcl.2012.09.063

T. Deng, J. Liu, P. Chung, D. Uehling, A. Aman et al., shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer, Cancer Research, vol.74, issue.7, pp.2119-2149, 2014.
DOI : 10.1158/0008-5472.CAN-13-2138

J. Li, J. Huang, J. Jeong, S. Park, R. Wei et al., Selective TBK1/IKKi dual inhibitors with anticancer potency, International Journal of Cancer, vol.228, issue.8, pp.1972-80, 2014.
DOI : 10.1002/jcp.24115

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947486

H. Makino, T. Saijo, Y. Ashida, H. Kuriki, and Y. Maki, Mechanism of Action of an Antiallergic Agent, Amlexanox (AA-673), in Inhibiting Histamine Release from Mast Cells, International Archives of Allergy and Immunology, vol.82, issue.1, pp.66-71, 1987.
DOI : 10.1159/000234292

S. Reilly, S. Chiang, S. Decker, L. Chang, M. Uhm et al., An inhibitor of the protein kinases TBK1 and IKK-?? improves obesity-related metabolic dysfunctions in mice, Nature Medicine, vol.2005, issue.3, pp.313-334, 2013.
DOI : 10.1126/stke.2682005pe4